Ação do Glucantime sobre macrófagos de camundongos

Ação do Glucantime sobre macrófagos de camundongos

Show other versions (1)

Os antimoniais pentavalentes, tais como o Glucantime, são geralmente usados como fármacos de primeira escolha para o tratamento das leishmanioses, no entanto seu mecanismo de ação não é completamente esclarecido. Atua contra formas amastigotas intracelulares de Leishmania sp, comprometendo o potenci...

Full description

Bibliographic Details
Main Author:	Larissa Moreira Siqueira
Other Authors:	Silvia Amaral Gonçalves da Silva
Format:	Others
Language:	Portuguese
Published:	Universidade do Estado do Rio de Janeiro 2014
Subjects:	Glucantime Macrófagos Imunomodulação Macrophage Immunomodulation PROTOZOOLOGIA DE PARASITOS
Online Access:	http://www.bdtd.uerj.br/tde_busca/arquivo.php?codArquivo=8379

Similar Items

Ação do Glucantime sobre macrófagos de camundongos
by: Larissa Moreira Siqueira
Published: (2014)

A Comparetaive Study on Glucantime and Oral Terbinafine along with Systemic Glucantime on Cutaneous Leishmaniasis
by: Saba Ebrahimian, et al.
Published: (2011-03-01)

PERILESIONAL INFILTRATION OF GLUCANTIME AND LIDOCAINE FOR TREATMENT OF LEISHMANIASIS
by: Reyes Alirio Torres, et al.
Published: (2000-05-01)

Comparison between intralesional glucantime injection and cryotherapy in papular cutaneous leishmaniasis
by: Yazdanpanah MJ, et al.
Published: (2006-10-01)

The Evaluation of Intralesional Glucantime and Cryotherapy plus Intralesional Glucantime Therapeutic Efficacy on Zoonotic Cutaneous Leishmaniasis: A Randomized Clinical Trial
by: Abedin Saghafipour, et al.
Published: (2017-12-01)

Tc1 Cells Percentage in Patients with Cutaneous Leishmaniasis before and after Treatment with Glucantime
by: M Mohajery, et al.
Published: (2007-05-01)

Tc1 Cells Percentage in Patients with Cutaneous Leishmaniasis before and after Treatment with Glucantime
by: M Mohajery, et al.
Published: (2007-03-01)

The Efficacy of Intralesional Injection of Glucantime with Mesotherapy for the Treatment of Cutanuos Leishmaniasis in Comparison to Classic Method
by: Zabiholah Shahmoradi, et al.
Published: (2011-03-01)

Comparing the Effects of Topical Miltefosine and Glucantime in Treatment of Cutaneous Leishmaniasis
by: Ali Asilian, et al.
Published: (2014-03-01)

Decreased effect of glucantime in cutaneous leishmaniasis complicated with secondary bacterial infection
by: G Sadeghian, et al.
Published: (2011-01-01)

The Effect of Local Allergic Reaction to Intralesional Glucantime on Recovery Course of Cutaneous Leishmaniasis
by: Saman Afkhami-Ardakani, et al.
Published: (2020-04-01)

Report of 103 cases of visceral Leishmaniasis
by: Tabatabaei P
Published: (1999-07-01)

Treatment Outcome of the Drug-resistant Zoonotic Cutaneous Leishmaniasis by Glucantime
by: Simindokht Soleimanifard, et al.
Published: (2017-01-01)

The Skin Side Effects of Topical Glucantime in Patients with Cutaneous Leishmaniasis
by: Mohammad Ali Nilforoushzadeh, et al.
Published: (2015-08-01)

The Efficacy of Achillea Millefolium Topical Gel Along with Intralesional Injection of Glucantime in the Treatment of Acute Cutaneous Leishmaniasis
by: Fariba Jaffary, et al.
Published: (2012-03-01)

The efficacy of Achilles millefolium topical gel along with intralesional injection of glucantime in the treatment of acute cutaneous leishmaniasis major
by: Fariba Jaffary, et al.
Published: (2014-01-01)

Clinical and laboratory evaluation of cured and non-cured patients with cutaneous leishmaniasis treated by Glucantime
by: F Ezatkhah, et al.
Published: (2019-01-01)

Immunopathology of american cutaneous leishmaniasis. Modulation of MHC class II gene products by Keratinocytes before and after glucantime therapy
by: Claude Pirmez, et al.
Published: (1990-06-01)

Calazar: Estudio de 18 pacientes en Brasil Kala-azar. Study of 18 patients in Brazil
by: Moisés Morejón García, et al.
Published: (2006-06-01)

Manifestações clínicas, laboratoriais e a função dos fagócitos em crianças com leishmaniose visceral tratadas com glucantime
by: Cardoso, Vanessa Viana
Published: (2010)

Niosomal formulation of amphotericin B alone and in combination with glucantime: In vitro and in vivo leishmanicidal effects
by: Mahshid Mostafavi, et al.
Published: (2019-08-01)

Comparison of intralesional two percent zinc sulfate and glucantime injection in treatment of acute cutaneous leishmaniasis
by: Masoud Maleki, et al.
Published: (2012-01-01)

A Comparison of the Effects of Topical Injection of Glucantime Plus Glycolic Acid 70% and Salicylic Acid 20% with Topical Injection of Glucantime Alone in the Treatment of Acute Cutaneous Leishmaniasis
by: Mohammad Ali Nilforoushzadeh, et al.
Published: (2017-04-01)

The effect of glucantime™ on the labeling of blood constituents with technetium-99m Efeito do glucantime™ na marcação de constituintes do sangue com tecnécio-99m
by: Cecília Maria Carvalho Xavier Holanda, et al.
Published: (2005-01-01)

In Vitro Study of Leishmanicidal Activity of Biogenic Selenium Nanoparticles against Iranian Isolate of Sensitive and Glucantime-Resistant Leishmania tropica
by: Hossein Mahmoudvand, et al.
Published: (2014-12-01)

Treatment of Glucantim™-Resistant Cutaneous Leishmaniasis Using Combination Therapy of Allopurinol and Trichloroacetic Acid (TCA) 50%; Report of Three Cases
by: Giti Sadeghian, et al.
Published: (2017-01-01)

Fe3O4@Bio-MOF Nanoparticles Combined with Artemisinin, Glucantime®, or Shark Cartilage Extract on Iranian Strain of Leishmania major (MRHO/IR/75/ER): An In-Vitro and In-Vivo Study
by: Fatemeh‌‌‌‌ GHAFARIFAR, et al.
Published: (2020-12-01)

Efficacy of miltefosine compared with glucantime for the treatment of cutaneous leishmaniasis: a systematic review and meta-analysis
by: Sohrab Iranpour, et al.
Published: (2019-03-01)

Visceral and cutaneous leishmaniasis in urban area of cartagena: a case report
by: Pinzón-Redondo Hernando, et al.
Published: (2012-06-01)

Visceral leishmaniasis in children
by: mandana Rafeey, et al.
Published: (2005-02-01)

Comparison of Th1 and Th2 Responses in Non-Healing and Healing Patients with Cutaneous Leishmaniasis
by: Maryam Shahi, et al.
Published: (2013-05-01)

HISTORICAL SERIES OF PATIENTS WITH VISCERAL LEISHMANIASIS TREATED WITH MEGLUMINE ANTIMONIATE IN A HOSPITAL FOR TROPICAL DISEASES, MACEIÓ-AL, BRAZIL
by: Lindon Johoson Diniz Silveira, et al.
Published: (2015-02-01)

Comparison of Thymus vulgaris (Thyme), Achillea millefolium (Yarrow) and propolis hydroalcoholic extracts versus systemic glucantime in the treatment of cutaneous leishmaniasis in balb/c mice
by: M.A. Nilforoushzadeh, et al.
Published: (2008-11-01)

P-glycoprotein A Gene Expression in Glucantime-Resistant and Sensitive Leishmania major (MRHO/IR/75/ER)
by: Simindokht Soleimanifard, et al.
Published: (2014-09-01)

Estudo comparativo entre o antimoniato-N-metilglucamina (Glucantime®) e o isotionato de pentamidina (Pentacarinat®) em lesões cutâneas da leishmaniose tegumentar
by: Sampaio, Gilmara de Souza
Published: (2014)

Da necessidade de se adotar e divulgar esquemas terapêuticos para tratamento de leishmaniose tegumentar no Paraná It's necessary to adopt and disseminate therapeutic schemes for the treatment of cutaneous leishmaniasis in Paraná State
by: Ueslei Teodoro, et al.
Published: (1991-06-01)

Basal cell carcinoma superimposed on a cutaneous leishmaniasis lesion in an immunocompromised patient
by: Ali Asilian, et al.
Published: (2012-01-01)

Biodistribution of meglumine antimoniate in healthy and Leishmania (Leishmania) infantum chagasi-infected BALB/c mice
by: Samanta Etel Treiger Borborema, et al.
Published: (2013-08-01)

Evaluation of synergistic therapeutic effect of shark cartilage extract with artemisinin and glucantime on visceral leishmaniasis in BALB/c mice
by: Soheila Molaie, et al.
Published: (2019-02-01)

Therapeutic Effect of Sodium Selenite and Zinc Sulphate as Supplementary with Meglumine Antimoniate( Glucantime®) Against Cutaneous Leishmaniasis In BALB/C Mice
by: M Mohebali, et al.
Published: (2010-09-01)

Cannot write session to /tmp/vufind_sessions/sess_2obavb1kqb1bvk39scftua4777